Mirae Asset Global ETFs Holdings
SKYE icon

Mirae Asset Global ETFs Holdings’s Skye Bioscience SKYE Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-269,734
Closed -$1.06M – 3185
2025
Q3 		$1.06M Sell
269,734
-20,245
-7% -$76.5K ﹤0.01% 1453
2025
Q2 		$1.21M Sell
289,979
-20,034
-6% -$41.5K ﹤0.01% 1352
2025
Q1 		$493K Sell
310,013
-16,228
-5% -$44.3K ﹤0.01% 1875
2024
Q4 		$923K Sell
326,241
-18,213
-5% -$76.1K ﹤0.01% 1587
2024
Q3 		$1.35M Buy
+344,454
New +$1.93M ﹤0.01% 1366

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's SKYE Position: Q4 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Skye Bioscience (SKYE) in Q4 2025, closing a stake of 269,734 shares — an estimated $1.06M sold.

Mirae Asset Global ETFs Holdings first reported a position in SKYE in Q3 2024 and held it in 5 quarters. The position peaked at $1.35M in Q3 2024. 50 funds tracked by Wall St. Rank hold SKYE as of Q4 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Skye Bioscience position as of Q4 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 269,734 Skye Bioscience shares in Q4 2025, an estimated $1.06M.
  • Mirae Asset Global ETFs Holdings first reported a position in Skye Bioscience in Q3 2024 and held it in 5 quarters.
  • Mirae Asset Global ETFs Holdings's Skye Bioscience position peaked at $1.35M in Q3 2024.
  • 50 funds tracked by Wall St. Rank held Skye Bioscience as of Q4 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.